HSP90 supports tumor growth and angiogenesis through PRKD2 protein stabilization

These findings indicate that oncogenic contributions of the kinase PRKD2 might be exploited to target particularly hypoxic tumors, with immediately actionable implications in the clinic with ongoing development of PRKD2 inhibitors.